ReviewCurrent cardiology reports2018
Pericardial Disease Associated with Malignancy.
Review in Current cardiology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 34 citations in OpenAlex.
- Trends, disparities and projections of pericardial diseases related mortality in the United States: A 1999-2035 analysis using artificial deep neural network.American heart journal plus : cardiology research and practice · 2026Article
- In-Hospital Mortality Among Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion with and Without Malignancy.Current oncology (Toronto, Ont.) · 2025Article
- An infusion port for recurrent massive pericardial effusion: a case report.European heart journal. Case reports · 2024Article
- Pericardial Disease in Patients with Cancer: Clinical Insights on Diagnosis and Treatment.Cancers · 2024Review
- Fatal Cardiac Tamponade: The Lethal Progression of Acute-on-Chronic Pericardial Effusion.Cureus · 2024Article
- Case report: Primary pericardial angiosarcoma, a rare cause of cardiac tamponade.Frontiers in cardiovascular medicine · 2024Article
- Case Report: A crushing sensation-a rare case of mediastinal germ cell tumor causing cardiac tamponade.Frontiers in cardiovascular medicine · 2024Article
- Article
- Article
- Diagnosis, treatment, and management of pericardial effusion- review.Annals of medicine and surgery (2012) · 2022Review
- Pericardial malignant infiltration as the cause of sudden death of a patient with metastatic urothelial carcinoma treated with atezolizumab.BMC urology · 2022Article
- Development and validation a simple scoring system to identify malignant pericardial effusion.Frontiers in oncology · 2022Article
- Advanced lung cancer presenting with malignant pericardial effusion.Clinical case reports · 2021Article
- Review
- Pulmonary hypertension concurrent with pericardial effusion and superior vena cava syndrome: who is the initiator?Journal of geriatric cardiology : JGC · 2020Article
- Treatment of Pericardial Effusion Through Subxiphoid Tube Pericardiostomy and Computerized Tomography- or Echocardiography - Guided Percutaneous Catheter Drainage Methods.Brazilian journal of cardiovascular surgeryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewPericardial effusion is commonly associated with malignancy. The goals of treatment should include optimizing symptom relief, minimizing repeat interventions, and restoring as much functional status as possible. RECENT
findingsPericardiocentesis should be the first intervention but has high recurrence rates (30-60%). For patients with recurrence, repeat pericardiocentesis is indicated in those with limited expected lifespans. Extended pericardial drainage decreases recurrence to 10-20%. The addition of sclerosing agents decreases recurrence slightly but creates significant pain and can lead to pericardial constriction and therefore has fallen out of favor. Most patients with symptomatic pericardial disease have a short median survival time due to their underlying disease. In patients with a longer life expectancy, surgical drainage offers the lowest recurrence rate. Surgical approach is based on effusion location and clinical condition. Subxiphoid and thoracoscopic approaches lead to similar outcomes. Thoracotomy should be avoided as it increases morbidity without improving outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.